English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

MBI announces updates to board of directorsqrcode

Jan. 6, 2016

Favorites Print
Forward
Jan. 6, 2016
The US biopesticide company Marrone Bio Innovations, Inc. (MBI) recently announced updates to its Board of Directors.
 
Michael Benoff has joined MBI's Board of Directors and Audit Committee.  Mr. Benoff has worked as independent consultant since 2008, advising clients on corporate strategy and corporate finance, including preparing business models, structuring debt acquisitions, managing capital markets transactions and advising on equity capitalization matters. Mr. Benoff previously served as the CFO of The Money Store Inc., retiring after its sale in 1999, after which he became active as a private investor.  Mr. Benoff is currently a board member of the Sacramento Tree Foundation. Mr. Benoff received his B.A. in Politics at Princeton University.
 
Mr. Benoff was appointed to a seat left vacant by Les Lyman, who resigned from MBI's Board of Directors effective January 4, 2016, for personal reasons.
 
In addition, Tim Fogarty, a member of MBI's Board of Directors since 2010, has been appointed as Chairperson of the Board. Mr. Fogarty is currently the Chief Financial Officer and a Partner of the Contrarian Group, Inc., an investment and management company which is also an investor in MBI through its limited partnership, CGI Opportunity Fund II, L.P. Prior to joining Contrarian Group in 2006, Mr. Fogarty held various financial and executive positions within the insurance industry. Mr. Fogarty has a Bachelors of Science Degree in Accounting and is a Certified Public Accountant in good standing in California.

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox